Slate Bio pulls in $1.75m
Slate Bio Inc, a pre-clinical stage biotechnology company that spun out of the University of Virginia, has raised $1.75 million in financing.
Slate Bio Inc, a pre-clinical stage biotechnology company that spun out of the University of Virginia, has raised $1.75 million in financing.
Copyright PEI Media
Not for publication, email or dissemination
